Autologous Bone Marrow Aspirate Concentrate

AssetAlso called BMAC

Autologous concentrated bone marrow cells delivering progenitor cells and anti-inflammatory factors for cartilage repair

Stage
Phase 3
Modality
Cell therapy
Target
Not known
2
Indications
1
Trial
1
Developer

Trial NCT06216028 is still running. clinicaltrials.gov

Indications

2

In the full profile

  • Owner and partners1
  • Trials1
  • Competitors12
  • Signals1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets